A private calibration companion
A private, claim-free planning companion for people who calibrate their own performance — microdosing, THC, adaptogens. It reasons over a curated knowledge base, then checks in the next morning to learn what actually worked for you. Nothing leaves the device.
The Economist and Google loaded a NotebookLM with 70+ research-grade sources — scientists, economists, year-ahead forecasts — and called it The World Ahead 2026.
The brief was: find market gaps that offer the best opportunities for a solo founder to build a company this year.
People using functional substances to manage focus have no tool to calibrate what works for them. So they improvise — group chats, Reddit threads, DIY spreadsheets. High effort, low confidence, grey zone.
"I tracked my brain fog for 6 months and tested everything."
"I just keep a notepad on my microwave."
"Switched to a spreadsheet."
Under-35s are walking away from alcohol toward deliberate, functional inputs. The spend is already here; the calibration layer isn't.
Under-35s who drink alcohol. Gallup
The brain is a knowledge base we build and own, running on-device. Competitors can't copy it, and no external model ever invents a dose.
The next-day check-in is the whole product — the only moment the app learns whether a plan worked, and why the next one is sharper. Retention engine and data moat, in one tap.
Alcohol apps (Reframe, Sunnyside) and cannabis apps (Releaf, Tetragram) each cover one substance, log what you took, and hand you community averages.
| Alcohol apps | Cannabis apps | Zebra Dose | |
|---|---|---|---|
| Substance scope | Single | Single | Cross-category |
| What it measures | Intake | Intake | Next-day outcome |
| Guidance model | Community avg. | Community avg. | Your own calibration |
| Data lives | In the cloud | In the cloud | On-device |
| Health claims | Recovery framing | Wellness framing | Claim-free |